Vered Daitch

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

Severe Infections, Health Sciences, Antibiotics +9

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar et al. · Clinical Infectious Diseases · 2018 · 119 citations

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Amir Nutman, Jonathan Lellouche, Elizabeth Temkin et al. · Clinical Microbiology and Infection · 2020 · 75 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +11

Characteristics of long-COVID among older adults: a cross-sectional study

Vered Daitch, Dana Yelin, Muhammad Awwad et al. · International Journal of Infectious Diseases · 2022 · 73 citations · Full text

Risk Factors and Multidimensional Assessment of Long Coronavirus Disease Fatigue: A Nested Case-Control Study

Ili Margalit, Dana Yelin, Moshe Sagi et al. · Clinical Infectious Diseases · 2022 · 60 citations · Full text